Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome.

Proceedings of the National Academy of Sciences of the United States of America
Edward A MiaoAlan Aderem

Abstract

The mammalian innate immune system uses Toll-like receptors (TLRs) and Nod-LRRs (NLRs) to detect microbial components during infection. Often these molecules work in concert; for example, the TLRs can stimulate the production of the proforms of the cytokines IL-1beta and IL-18, whereas certain NLRs trigger their subsequent proteolytic processing via caspase 1. Gram-negative bacteria use type III secretion systems (T3SS) to deliver virulence factors to the cytosol of host cells, where they modulate cell physiology to favor the pathogen. We show here that NLRC4/Ipaf detects the basal body rod component of the T3SS apparatus (rod protein) from S. typhimurium (PrgJ), Burkholderia pseudomallei (BsaK), Escherichia coli (EprJ and EscI), Shigella flexneri (MxiI), and Pseudomonas aeruginosa (PscI). These rod proteins share a sequence motif that is essential for detection by NLRC4; a similar motif is found in flagellin that is also detected by NLRC4. S. typhimurium has two T3SS: Salmonella pathogenicity island-1 (SPI1), which encodes the rod protein PrgJ, and SPI2, which encodes the rod protein SsaI. Although PrgJ is detected by NLRC4, SsaI is not, and this evasion is required for virulence in mice. The detection of a conserved component...Continue Reading

References

Aug 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·T KuboriJ E Galán
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·T G Kimbrough, S I Miller
Oct 25, 2000·Protein Science : a Publication of the Protein Society·A FiserA Sali
Sep 12, 2001·Journal of Structural Biology·R BonneauD Baker
Nov 1, 2001·Annual Review of Cell and Developmental Biology·J E Galán
Feb 5, 2002·Microbes and Infection·Tyler G Kimbrough, Samuel I Miller
Oct 31, 2003·Experimental Hematology·Toshio KitamuraHidetoshi Kumagai
Jun 11, 2004·Nature·Sanjeev MariathasanVishva M Dixit
Jul 2, 2004·Nature Reviews. Immunology·Shizuo Akira, Kiyoshi Takeda
Nov 6, 2004·Science·Thomas C MarlovitsVinzenz M Unger
Mar 24, 2005·Infection and Immunity·Susan L Fink, Brad T Cookson
Jun 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Erica Andersen-NissenAlan Aderem
Jun 28, 2005·Nucleic Acids Research·Lukasz JaroszewskiAdam Godzik
Apr 12, 2006·The Journal of Experimental Medicine·Ari B MolofskyMichele S Swanson
Apr 25, 2006·Journal of Molecular Biology·Lingling ZhangRoberto N De Guzman
May 24, 2006·The Journal of Experimental Medicine·Maria Lara-TejeroJorge E Galán
Sep 21, 2006·The Journal of Biological Chemistry·Amal AmerGabriel Núñez
Dec 1, 2006·Nature·Jorge E Galán, Hans Wolf-Watz
Jul 10, 2007·Journal of Molecular Biology·Yu WangRoberto N De Guzman
Aug 11, 2007·Seminars in Immunopathology·Edward A MiaoAlan Aderem
Aug 23, 2007·BMC Bioinformatics·László Kaján, Leszek Rychlewski
Oct 4, 2007·The Journal of Biological Chemistry·Yao-Hui SunRenée M Tsolis
Oct 16, 2007·European Journal of Immunology·Luigi FranchiGabriel Núñez
Dec 12, 2007·The Journal of Experimental Medicine·Fayyaz S SutterwalaRichard A Flavell
Feb 8, 2008·Proceedings of the National Academy of Sciences of the United States of America·Edward A MiaoAlan Aderem
May 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sarah E WarrenAlan Aderem
Jan 6, 2009·Immunological Reviews·Mohamed Lamkanfi, Vishva M Dixit

❮ Previous
Next ❯

Citations

May 15, 2013·EMBO Molecular Medicine·Franz Bauernfeind, Veit Hornung
Mar 30, 2010·Journal of Clinical Immunology·Edward A Miao, Sarah E Warren
Aug 21, 2013·In Vitro Cellular & Developmental Biology. Animal·Maozhi HuXinan Jiao
May 29, 2013·Trends in Microbiology·Naomi HigaToshihiko Suzuki
Oct 22, 2010·Mucosal Immunology·P D SmithS M Wahl
Aug 21, 2012·Nature·Jakob von MoltkeRussell E Vance
Mar 31, 2010·Nature Immunology·Vijay A K RathinamKatherine A Fitzgerald
Jan 20, 2011·Nature Immunology·Thomas A Kufer, Philippe J Sansonetti
Mar 21, 2012·Nature Immunology·Luigi FranchiGabriel Núñez
Mar 21, 2012·Nature Immunology·Vijay A K RathinamKatherine A Fitzgerald
Aug 21, 2013·Nature Reviews. Gastroenterology & Hepatology·Wajahat Z Mehal
Feb 26, 2011·Nature Reviews. Immunology·Mohamed Lamkanfi
Jul 13, 2013·Nature Reviews. Immunology·Petr Broz, Denise M Monack
Sep 14, 2012·The New England Journal of Medicine·W Joost WiersingaSharon J Peacock
May 12, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jonathan W JonesDenise M Monack
Dec 2, 2010·Proceedings of the National Academy of Sciences of the United States of America·Bo HuRichard A Flavell
Jul 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·John-Demian SauerDaniel A Portnoy
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Delphyne DescampsJean-Michel Sallenave
Aug 14, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jieling YangFeng Shao
Jun 2, 2012·The Journal of Biological Chemistry·Dalian ZhongRoberto N De Guzman
Feb 8, 2011·The Journal of Biological Chemistry·Hal M Hoffman, Susannah D Brydges
Jul 7, 2010·The Journal of Experimental Medicine·Petr BrozDenise M Monack
Jan 18, 2013·International Immunology·Amlan Biswas, Koichi S Kobayashi
Nov 8, 2012·Current Opinion in Gastroenterology·Susan J Robertson, Stephen E Girardin
Aug 7, 2010·Current Opinion in Infectious Diseases·Margaret KosekMaribel Paredes Olortegui
Jun 23, 2012·Open Biology·Clare E Bryant, Tom P Monie
Sep 18, 2012·Science·Luigi Franchi, Gabriel Núñez
Jan 26, 2013·Science·Youssef AachouiEdward A Miao
Jul 21, 2010·Infection and Immunity·Natalia MuñozJosé A Chabalgoity
Feb 2, 2011·Infection and Immunity·Karla L LightfieldRussell E Vance

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.